A randomised, double-blind clinical phase II trial of the efficacy, safety, tolerability and pharmacokinetics of a single dose combination treatment with artefenomel and piperaquine in adults and children with uncomplicated Plasmodium falciparum malaria

被引：0

作者：

Fiona Macintyre

Yeka Adoke

Alfred B. Tiono

Tran Thanh Duong

Ghyslain Mombo-Ngoma

Marielle Bouyou-Akotet

Halidou Tinto

Quique Bassat

Saadou Issifou

Marc Adamy

Helen Demarest

Stephan Duparc

Didier Leroy

Bart E. Laurijssens

Sophie Biguenet

Afizi Kibuuka

Antoinette Kitoto Tshefu

Melnick Smith

Chanelle Foster

Illse Leipoldt

Peter G. Kremsner

Bui Quang Phuc

Alphonse Ouedraogo

Michael Ramharter

机构：

[1] Medicines for Malaria Venture,Infectious Diseases Research Collaboration

[2] Tororo Hospital,Universite des Sciences de la Sante Gabon, Département de Parasitology, Malaria Clinical and Operational Research Unit

[3] Centre National de Recherche et de Formation sur le Paludisme,Centre de Recherche du Centre Hospitalier de Mont Amba, Kinshasa School of Public Health

[4] National Institute of Malariology,Department of Medicine I, Division of Infectious Diseases

[5] Parasitology and Entomology,undefined

[6] Centre de Recherches Médicales de Lambaréné,undefined

[7] Institut für Tropenmedizin,undefined

[8] Universität Tübingen,undefined

[9] Melen Hospital,undefined

[10] Institut de Recherche en Sciences de la Santé – Unité de Recherche Clinique de Nanoro,undefined

[11] ISGlobal,undefined

[12] Barcelona Ctr. Int. Health Res. (CRESIB),undefined

[13] Hospital Clínic - Universitat de Barcelona,undefined

[14] Centro de Investigação em Saúde de Manhiça (CISM),undefined

[15] ICREA,undefined

[16] Pediatric Infectious Diseases Unit,undefined

[17] Pediatrics Department,undefined

[18] Hospital Sant Joan de Déu (University of Barcelona),undefined

[19] Universidad Europea de Madrid,undefined

[20] Centre de Recherche sur le Paludisme Associé à la Grossesse et l’Enfance,undefined

[21] Faculte Des Sciences De La Sante,undefined

[22] BEL Pharm Consulting,undefined

[23] University of Kinshasa,undefined

[24] QuintilesIMS,undefined

[25] Department: Biostatistics,undefined

[26] Medical University of Vienna,undefined

[27] Bernhard Nocht Hospital for Tropical Diseases,undefined

[28] Bernhard Nocht Institute for Tropical Medicine and University Medical Center Hamburg-Eppendorf,undefined

来源：

BMC Medicine | / 15卷

关键词：

Artefenomel; OZ439; Piperaquine; Single dose combination treatment; Pharmacokinetics; Dose–response; modelling and simulation; Phase II B; Uncomplicated ; malaria; Children;

D O I：

暂无

中图分类号：

学科分类号：

摘要：

引用

共 50 条

[21] Artesunate and sulfadoxine-pyrimethamine combinations for the treatment of uncomplicated Plasmodium falciparum malaria in Uganda:: a randomized, double-blind, placebo-controlled trial
Priotto, G
Kabakyenga, J
Pinoges, L
Ruiz, A
Eriksson, T
Coussement, F
Ngambe, T
Taylor, WRJ
Perea, W
Guthmann, JP
Olliaro, P
Legros, D
TRANSACTIONS OF THE ROYAL SOCIETY OF TROPICAL MEDICINE AND HYGIENE, 2003, 97 (03) : 325 - 330
[22] EFFICACY, SAFETY AND TOLERABILITY STUDY OF ARTEMISININ-PIPERAQUINE COMBINATION (ARTEQUICKR) VERSUS ARTEMETER-LUMEFANTRINE (CO-ARTEMR) FOR THE TREATMENT OF UNCOMPLICATED PLASMODIUM FALCIPARUM T MALARIA IN IJEBU ODE LOCAL GOVERNMENT HEALTH SERVICES IN NIGERIA
Onasanya, S. S.
Tijani, R. O.
Onasanya, T. O.
Alayo, M.
Akinbajo, A. E.
CLINICAL THERAPEUTICS, 2015, 37 (08) : E9 - E9
[23] Efficacy and safety of ivermectin for the treatment of Plasmodium falciparum infections in asymptomatic male and female Gabonese adults - a pilot randomized, double-blind, placebo-controlled single-centre phase Ib/IIa clinical trial
Mbassi, Dorothea Ekoka
Mombo-Ngoma, Ghyslain
Held, Jana
Okwu, Dearie Glory
Ndzebe-Ndoumba, Wilfrid
Kalkman, Laura Charlotte
Mbassi, Franck Aurelien Ekoka
de Carvalho, Lais Pessanha
Inoue, Juliana
Akinosho, Malik Azeez
Mbadinga, Lia Betty Dimessa
Yovo, Emmanuel Koffi
Mordmueller, Benjamin
Kremsner, Peter Gottfried
Adegnika, Ayola Akim
Ramharter, Michael
Zoleko-Manego, Rella
EBIOMEDICINE, 2023, 97
[24] Randomized, multicentre assessment of the efficacy and safety of ASAQ – a fixed-dose artesunate-amodiaquine combination therapy in the treatment of uncomplicated Plasmodium falciparum malaria
Jean Louis Ndiaye
Milijaona Randrianarivelojosia
Issaka Sagara
Philippe Brasseur
Ibrahima Ndiaye
Babacar Faye
Laurence Randrianasolo
Arsène Ratsimbasoa
Doris Forlemu
Vicky Ama Moor
Aminata Traore
Yahia Dicko
Niawanlou Dara
Valérie Lameyre
Mouctar Diallo
Abdoulaye Djimde
Albert Same-Ekobo
Oumar Gaye
Malaria Journal, 8
[25] Primaquine to reduce transmission of Plasmodium falciparum malaria in Mali: a single-blind, dose-ranging, adaptive randomised phase 2 trial
Dicko, Alassane
Brown, Joelle M.
Diawara, Halimatou
Baber, Ibrahima
Mahamar, Almahamoudou
Soumare, Harouna M.
Sanogo, Koualy
Koita, Fanta
Keita, Sekouba
Traore, Sekou F.
Chen, Ingrid
Poirot, Eugenie
Hwang, Jimee
McCulloch, Charles
Lanke, Kjerstin
Pett, Helmi
Niemi, Mikko
Nosten, Francois
Bousema, Tevn
Gosling, Roly
LANCET INFECTIOUS DISEASES, 2016, 16 (06) : 674 - 684
[26] Randomized, multicentre assessment of the efficacy and safety of ASAQ - a fixed-dose artesunate-amodiaquine combination therapy in the treatment of uncomplicated Plasmodium falciparum malaria
Ndiaye, Jean Louis
Randrianarivelojosia, Milijaona
Sagara, Issaka
Brasseur, Philippe
Ndiaye, Ibrahima
Faye, Babacar
Randrianasolo, Laurence
Ratsimbasoa, Arsene
Forlemu, Doris
Moor, Vicky Ama
Traore, Aminata
Dicko, Yahia
Dara, Niawanlou
Lameyre, Valerie
Diallo, Mouctar
Djimde, Abdoulaye
Same-Ekobo, Albert
Gaye, Oumar
MALARIA JOURNAL, 2009, 8
[27] Efficacy and safety of dihydroartemisinin–piperaquine for treatment of Plasmodium falciparum uncomplicated malaria in adult patients on antiretroviral therapy in Malawi and Mozambique: an open label non-randomized interventional trial
Esperança Sevene
Clifford G. Banda
Mavuto Mukaka
Sonia Maculuve
Salésio Macuacua
Anifa Vala
Mireia Piqueras
Linda Kalilani-Phiri
Jane Mallewa
Dianne J. Terlouw
Saye H. Khoo
David G. Lalloo
Victor Mwapasa
Malaria Journal, 18
[28] Efficacy and safety of dihydroartemisinin-piperaquine versus artemether-lumefantrine for treatment of uncomplicated Plasmodium falciparum malaria in Ugandan children: a systematic review and meta-analysis of randomized control trials
Assefa, Dawit Getachew
Zeleke, Eden Dagnachew
Bekele, Delayehu
Tesfahunei, Hanna Amanuel
Getachew, Emnet
Joseph, Michele
Manyazewal, Tsegahun
MALARIA JOURNAL, 2021, 20 (01)
[29] Single low dose primaquine to reduce gametocyte carriage and Plasmodium falciparum transmission after artemether-lumefantrine in children with asymptomatic infection: a randomised, double-blind, placebo-controlled trial
Goncalves, Bronner P.
Tiono, Alfred B.
Ouedraogo, Alphonse
Guelbeogo, Wamdaogo M.
Bradley, John
Nebie, Issa
Siaka, Debe
Lanke, Kjerstin
Eziefula, Alice C.
Diarra, Amidou
Pett, Helmi
Bougouma, Edith C.
Sirima, Sodiomon B.
Drakeley, Chris
Bousema, Teun
BMC MEDICINE, 2016, 14
[30] Efficacy and safety of dihydroartemisinin-piperaquine for treatment of Plasmodium falciparum uncomplicated malaria in adult patients on antiretroviral therapy in Malawi and Mozambique: an open label non-randomized interventional trial
Sevene, Esperanca
Banda, Clifford G.
Mukaka, Mavuto
Maculuve, Sonia
Macuacua, Salesio
Vala, Anifa
Piqueras, Mireia
Kalilani-Phiri, Linda
Mallewa, Jane
Terlouw, Dianne J.
Khoo, Saye H.
Lalloo, David G.
Mwapasa, Victor
MALARIA JOURNAL, 2019, 18 (01)

← 1 2 3 4 5 →